128 related articles for article (PubMed ID: 31721157)
1. Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report.
Schmelz JL; Navsaria L; Goswamy R; Chuang HH; Miranda RN; Lee HJ
Br J Haematol; 2020 Feb; 188(3):e5-e8. PubMed ID: 31721157
[No Abstract] [Full Text] [Related]
2. Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma.
Deol A; Uberti J
Am J Hematol; 2020 Mar; 95(3):333-334. PubMed ID: 31429117
[No Abstract] [Full Text] [Related]
3. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
4. Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
Qasrawi A; Arora R; Ramlal R; Munker R; Hildebrandt GC
Am J Hematol; 2020 Apr; 95(4):E89-E91. PubMed ID: 31919891
[No Abstract] [Full Text] [Related]
5. Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Gorospe L; Gallego-Rivera JI; Rioja-Martín ME; Chinea-Rodríguez A
Ann Hematol; 2017 Jun; 96(6):1059-1060. PubMed ID: 28374164
[No Abstract] [Full Text] [Related]
6. Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).
Prusila REI; Peroja P; Jantunen E; Turpeenniemi-Hujanen T; Kuittinen O
Hematol Oncol; 2019 Apr; 37(2):136-142. PubMed ID: 30589950
[TBL] [Abstract][Full Text] [Related]
7. Impact of Increasing Wait Times on Overall Mortality of Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma: A Discrete Event Simulation Model.
Tully S; Feng Z; Grindrod K; McFarlane T; Chan KKW; Wong WWL
JCO Clin Cancer Inform; 2019 Oct; 3():1-9. PubMed ID: 31644324
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma of the lung in a patient with nonspecific interstitial pneumonia.
Gorospe Sarasúa L; Arrieta P; Chinea-Rodríguez A; de la Puente-Bujidos C
Reumatol Clin (Engl Ed); 2019; 15(6):e151-e152. PubMed ID: 28867466
[No Abstract] [Full Text] [Related]
9. Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae.
Marks R; Engelhardt M; Hager S; Füllgraf H; Südkamp NP; Herget GW
Ann Hematol; 2018 Aug; 97(8):1497-1500. PubMed ID: 29574568
[No Abstract] [Full Text] [Related]
10. Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis.
Eule C; Arora N; Li HC; Sadeghi N
Acta Oncol; 2020 Jul; 59(7):786-788. PubMed ID: 32233823
[No Abstract] [Full Text] [Related]
11. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
12. Shape of the Heart: A 68-Year-Old Man With a Primary Cardiac Non-Hodgkin Lymphoma.
Kil WJ
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):460-461. PubMed ID: 32014143
[No Abstract] [Full Text] [Related]
13. A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
Advani P; Paulus A; Murray P; Jiang L; Goff R; Pooley R; Jain M; Garner H; Foran J
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e117-20. PubMed ID: 25617034
[No Abstract] [Full Text] [Related]
14. "Do Not Ignore Musculoskeletal Pain"-Initial Presentation of a Rare Malignant Disease: Case Report and Literature Review.
Patel I; Akoluk A; Upadhyaya V; Makadia S; Douedi S; Farooq T; Flynn D; Levitt M; Hossain MA
J Investig Med High Impact Case Rep; 2020; 8():2324709620941316. PubMed ID: 32660277
[TBL] [Abstract][Full Text] [Related]
15. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
16. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.
Vassilakopoulos TP; Pangalis GA; Chatziioannou S; Papageorgiou S; Angelopoulou MK; Galani Z; Kourti G; Prassopoulos V; Leonidopoulou T; Terpos E; Dimopoulou MN; Sachanas S; Kalpadakis C; Konstantinidou P; Boutsis D; Stefanoudaki E; Kyriazopoulou L; Siakantaris MP; Kyrtsonis MC; Variami E; Kotsianidis I; Symeonidis A; Michali E; Katodritou E; Kokkini G; Tsatalas C; Papadaki H; Dimopoulos MA; Sotiropoulos V; Pappa V; Karmiris T; Meletis J; Apostolidis J; Datseris I; Panayiotidis P; Konstantopoulos K; Roussou P; Rondogianni P
Leukemia; 2016 Jan; 30(1):238-42. PubMed ID: 25971363
[No Abstract] [Full Text] [Related]
17. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
18. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA
Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671
[TBL] [Abstract][Full Text] [Related]
19. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Lamar ZS; Fino N; Palmer J; Gruber L; Morris BB; Raetskaya-Solntseva O; Kennedy L; Vaidya R; Hurd D; Zamkoff K
Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):76-81. PubMed ID: 26725264
[TBL] [Abstract][Full Text] [Related]
20. Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.
Pejša V; Prka Ž; Lucijanić M; Mitrović Z; Piršić M; Jakšić O; Ajduković R; Kušec R
Croat Med J; 2017 Feb; 58(1):40-48. PubMed ID: 28252874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
